UK | pharmaphorum

UK

News

UK places order for 60m doses of Sanofi/GSK’s COVID-19 vacci...

The UK government has signed its fourth coronavirus vaccine deal, snapping up 60 million doses of an experimental shot being developed by Sanofi and GlaxoSmithKline.

News

Great Britain £50 - fifty pounds sterling notes spead out.

UK pharma resilient in 2Q, despite pandemic fallout

UK manufacturing exports fell sharply during the second quarter as the COVID-19 pandemic gathered pace, but pharma and healthcare products were much less affected, says a

Views & Analysis

MSD’s David Peacock on moving UK healthcare forward

David Peacock has worked across the world for MSD and other companies, and has now taken the helm of MSD’s UK & Ireland operations.

Views & Analysis

Making it as an oncology biotech in the united kingdom

Making it as an oncology biotech in the UK

We speak to R&D experts to find out how oncology biotechs can get the support they need to be successful in the competitive UK ecosystem

News

Medical charities “slipping through cracks” of UK pandemic s...

Charities have already been hit hard by the coronavirus pandemic and lockdown, and Cancer Research UK says it could have to cut £150 million from much-needed research funding a

News

‘Swab-free’ coronavirus test on trial in the UK

Researchers in the UK have started testing a coronavirus test that would do away with the need to swab the nose and throat, and instead use a saliva sample that could be easily

UK places order for 60m doses of Sanofi/GSK’s COVID-19 vacci...

UK pharma resilient in 2Q, despite pandemic fallout

MSD’s David Peacock on moving UK healthcare forward

Making it as an oncology biotech in the UK

Medical charities “slipping through cracks” of UK pandemic s...

‘Swab-free’ coronavirus test on trial in the UK

Biotech is back, with Craig Ackerman

Using AI-driven synthetic personas to take your insights fur...

UK

Editor's Picks